ProLung, Inc. Appoints Kristin M. Larson, NP, as Director of Clinical Affairs
ProLung, Inc., ("ProLung" or the "Company") the world leader in innovative predictive analytics technology and non-invasive tests for the risk stratification of lung cancer, announces today the appointment of Kristin M. Larson, NP, to Director of Clinical Affairs.
View full press release